Menopause and Skin: What Oestrogen Decline Actually Does and What Helps

Published: May 2026  ·  Reading time: approx. 9 minutes

The four systems oestrogen decline disrupts simultaneously

Oestrogen is not a single-function hormone for the skin. It operates through oestrogen receptors expressed in keratinocytes, fibroblasts, sebaceous glands, vascular endothelium and melanocytes - almost every cell type in the skin has oestrogen receptor expression. When oestrogen falls, it does not affect one pathway. It affects the regulation of multiple systems concurrently. This is why menopausal skin changes feel sudden and overwhelming: several structural and functional deficits emerge at approximately the same time.

System 1: the barrier - ceramide loss and elevated TEWL

The skin barrier is built from ceramides, cholesterol and free fatty acids arranged in lamellar bilayers within the stratum corneum. These lipids form the structural architecture that determines how much moisture the skin retains and how much of the external environment reaches the living tissue below. Oestrogen plays a direct role in this: oestrogen receptors in keratinocytes regulate ceramide biosynthesis, and reduced oestradiol measurably reduces both ceramide abundance and ceramide chain length in the stratum corneum.

A 2022 study published in Scientific Reports measured stratum corneum ceramides in pre-menopausal, post-menopausal and HRT-treated post-menopausal women. Post-menopausal women showed significantly lower ceramide levels and shorter average chain lengths than pre-menopausal women. Critically, shorter-chain ceramides cannot form effective lamellar bilayers - they increase membrane permeability rather than reducing it. This produces a paradox: the skin tries to compensate by generating more stratum corneum cells, but those cells lack the proper lipid composition to function effectively as a barrier.

The consequences of this barrier deficit extend beyond dryness. Elevated TEWL exposes sensory nerve endings to external inputs that the intact barrier would have filtered. Products previously well-tolerated now sting or produce reactive episodes. Temperature changes that caused brief discomfort now cause prolonged flushing. Fragrance ingredients that caused no reaction at 35 reliably trigger redness at 45. The barrier system is the foundational deficit - everything else is amplified by it.

System 2: the structural - collagen, elastin, and hyaluronic acid

The dermis is maintained by fibroblasts - cells that produce collagen, elastin and the proteoglycans including hyaluronic acid that give the skin its structural volume and elasticity. Oestrogen receptors on fibroblasts stimulate their activity. When oestrogen declines, fibroblast activity slows, collagen synthesis decreases, collagen crosslinking becomes less efficient, and existing collagen is degraded faster than it is replaced.

The scale of this loss is clinically significant. Observational and histological studies by Brincat et al., confirmed in the 2025 Journal of Cosmetic Dermatology narrative review by Viscomi et al., found that skin collagen content declines at approximately 2.1% per post-menopausal year over a 15-year period. Approximately 30% of skin collagen is lost in the first five years following menopause alone - a rate of loss that significantly exceeds chronological ageing. Skin thickness also declines at approximately 1% per post-menopausal year.

Hyaluronic acid loss compounds the structural deficit. The 2025 narrative review also found reduced CD44 expression post-menopause - CD44 is the receptor for hyaluronic acid that is essential for skin hydration and extracellular matrix homeostasis. Even well-formulated hyaluronic acid serums cannot fully compensate for reduced receptor expression.

System 3: the vascular - flushing, redness and increased reactivity

Oestrogen contributes directly to peripheral vascular regulation through its effects on nitric oxide synthase in vascular endothelium. Nitric oxide is the primary vasodilatory signalling molecule in dermal blood vessels - it controls the diameter and tone of capillaries in the facial skin. When oestrogen levels fall, nitric oxide synthesis decreases and the precision of vascular regulation diminishes. Blood vessels dilate more readily, take longer to return to baseline constriction, and respond to lower-intensity inputs - heat, stress, alcohol, temperature change - with stronger and more prolonged vasodilation.

This is the mechanism behind both hot flushes (affecting approximately 75% of menopausal women) and the emergence or worsening of rosacea and couperose in the perimenopausal and post-menopausal years. The EMJ Dermatology 2025 clinician review confirmed that vasomotor flushing combined with increased skin sensitivity can directly aggravate rosacea in women with existing vascular predisposition.

The vascular system deficit interacts destructively with the barrier deficit: a compromised barrier allows external inputs to reach vascular nerve endings with less filtration, and the vascular response itself causes micro-inflammatory episodes that further damage the barrier. Breaking this cycle requires both barrier restoration and vascular calming in parallel.

System 4: the renewal - cell turnover and dullness

Oestrogen receptors in keratinocytes influence cell proliferation - the rate at which new cells are generated and old cells shed. In younger skin, the epidermal renewal cycle runs at approximately 28 days. As oestrogen declines, this cycle slows progressively - extending to 40-60 days in post-menopausal skin. The practical consequences are visible: a thicker accumulation of older, less reflective cells on the surface produces dullness, and uneven shedding produces texture irregularities and a patchy, inconsistent tone.

Slower renewal also means slower recovery from any disruption. A reactive episode, a product reaction, a sun exposure event - any of these takes longer to heal and leaves longer-lasting marks on skin with a slowed renewal cycle. Post-inflammatory redness persists longer. Hyperpigmentation from minor trauma fades more slowly.

The renewal system is the last of the four to be addressed in a recalibrated routine, and deliberately so. Chemical exfoliation and retinoids are the most effective renewal interventions - but both require an intact barrier to function without causing further disruption. Introducing them before the barrier is restored reliably produces the irritation, stinging and reactive episodes that send many women cycling back to basics.

Why the routine that worked at 35 fails at 45

The skincare industry has two primary frameworks: acne-focused for younger skin and anti-ageing for skin 35+. The anti-ageing framework typically involves exfoliation for cell turnover, retinoids for collagen, vitamin C for brightness and SPF for protection. For pre-menopausal skin with adequate barrier function, this framework is often well-calibrated.

Menopausal skin has structurally shifted. A routine built for adequate-barrier skin now operates on compromised-barrier skin. The retinoid penetrates more deeply than intended and triggers irritation. The AHA exfoliant disrupts a lamellar matrix that is already depleted and raises TEWL further. The vitamin C serum's acid pH stings. The fragrance in the moisturiser triggers vascular reactivity. None of these products has changed. The skin's capacity to absorb their inputs without disruption has.

Ingredients by system: what actually works

The correct sequence: barrier first, actives second

The four-system framework has a built-in sequencing logic: the barrier system must be addressed first because it amplifies the dysfunction of every other system. A compromised barrier makes structural actives more irritating, vascular reactivity more severe, and renewal interventions more disruptive. Restoring barrier integrity - ceramide density, lamellar architecture, reduced TEWL - raises the threshold at which everything else can be safely introduced.

The practical sequence for recalibrating a menopausal skincare routine:

• Weeks 1-4: barrier phase. Non-stripping cleanser, ceramide preparation on damp skin, Ectoin-containing calming product for vascular support in parallel, mineral SPF. Complete pause on all actives. If skin is actively reactive, this phase may need to extend to six to eight weeks.
• Weeks 4-8: structural introduction. Once skin tolerates the barrier routine without stinging or reactive episodes, introduce one structural active. Peptide-containing preparation is the lowest-irritation first choice. Vitamin C can be introduced at low concentration. Monitor for two to three weeks before adding anything further.
• Week 8+: renewal consideration. Once the structural layer is stable, consider a very gentle renewal step - PHA or low-percentage lactic acid at one to two times per week maximum. Retinoids are the most effective renewal and structural intervention but require the most gradual introduction: one evening per week at lowest available concentration, buffered between ceramide applications.

A note on HRT and skin

Hormone replacement therapy is a medical intervention with documented skin benefits, and it is worth mentioning briefly in any thorough account of menopausal skin.

The 2022 Scientific Reports ceramide study found that post-menopausal women on HRT maintained ceramide levels and ceramide chain lengths comparable to pre-menopausal women - the most direct evidence available that systemic oestrogen restoration addresses the barrier system at its root rather than compensating at the surface. The 2025 Journal of Cosmetic Dermatology review by Viscomi et al. confirmed HRT partially restores reduced skin elasticity and viscoelasticity in post-menopausal women.

Whether HRT is appropriate for any individual involves considerations far beyond skin - cardiovascular, oncological, quality of life and symptom severity all factor into the decision. This is a conversation for a GP or gynaecologist, not a skincare article. But for women who are medically appropriate candidates, the skin benefits are a documented consequence of systemic hormonal restoration, not a secondary effect.

Frequently asked questions

Explore the Hormonal and Menopausal Skin collection for formulations built around the four-system framework - ceramides, peptides, Ectoin and exosome technology working in sequence.

© NAYA Skincare. All information is for educational purposes only and does not constitute medical advice. For HRT or medical decisions, please consult a qualified healthcare professional.